High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
Oeda T, Masaki M, Yamamoto K, Mizuta E, Kitagawa N, Isono T, Taniguchi S, Doi K, Yaku H, Yutani C, Kawamura T, Kuno S, Sawada H.
Oeda T, et al.
J Neural Transm (Vienna). 2009 Feb;116(2):171-8. doi: 10.1007/s00702-008-0160-2. Epub 2008 Dec 10.
J Neural Transm (Vienna). 2009.
PMID: 19082526